NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 37 filers reported holding NUVECTIS PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BALDWIN BROTHERS LLC/MA | 168,630 | $1,067,428 | 0.08% |
| FORBES J M & CO LLP | 47,419 | $300,162 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 48,339 | $306 | 0.02% |
| Point72 Asia (Singapore) Pte. Ltd. | 9,203 | $58,252 | 0.01% |
| BAXTER BROS INC | 12,500 | $79,125 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 23,173 | $146,685 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 19,170 | $121,346 | 0.00% |
| Renaissance Technologies | 74,500 | $471,585 | 0.00% |
| Centiva Capital, LP | 13,300 | $84,189 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,996 | $37,955 | 0.00% |